Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$7.51 - $10.12 $148,675 - $200,345
-19,797 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$7.89 - $12.23 $315,229 - $488,625
-39,953 Reduced 66.87%
19,797 $194,000
Q4 2018

Feb 14, 2019

BUY
$7.29 - $15.27 $46,291 - $96,964
6,350 Added 11.89%
59,750 $467,000
Q3 2018

Nov 14, 2018

BUY
$5.82 - $17.47 $310,788 - $932,897
53,400 New
53,400 $660,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $113M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.